|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Breast Cancer | |||||
| Adenocarcinoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Breast Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Breast Diseases | |||||
| Carcinoma | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Skin Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| MDX-010 | |||||
| 5 | Sponsors listed in this trial | ||||
| Medarex | |||||